| 000 | 01427 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250514032118.0 | ||
| 264 | 0 | _c20020927 | |
| 008 | 200209s 0 0 eng d | ||
| 022 | _a0928-0987 | ||
| 024 | 7 |
_a10.1016/s0928-0987(02)00015-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTaub, Mitchell E | |
| 245 | 0 | 0 |
_aOptimized conditions for MDCK permeability and turbidimetric solubility studies using compounds representative of BCS classes I-IV. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences _cMay 2002 |
||
| 300 |
_a331-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiological Transport, Active _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Membrane Permeability _xdrug effects |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aExcipients _xclassification |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 | _aNephelometry and Turbidimetry |
| 650 | 0 | 4 | _aSolubility |
| 700 | 1 | _aKristensen, Lisbeth | |
| 700 | 1 | _aFrokjaer, Sven | |
| 773 | 0 |
_tEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences _gvol. 15 _gno. 4 _gp. 331-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0928-0987(02)00015-5 _zAvailable from publisher's website |
| 999 |
_c11888004 _d11888004 |
||